Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 - Test2 - elhamkhani - TriplyDB

Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3

Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3

http://www.wikidata.org/entity/Q34393166

about

Adeno-associated Virus as a Mammalian DNA Vector Structure of AAV-DJ, a Retargeted Gene Therapy Vector: Cryo-Electron Microscopy at 4.5 Å Resolution Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo.Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.Intracellular transport of recombinant adeno-associated virus vectors.The SUMOylation Pathway Restricts Gene Transduction by Adeno-Associated Viruses The AAV vector toolkit: poised at the clinical crossroads Methods for gene transfer to the central nervous system.Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia.In vivo tissue-tropism of adeno-associated viral vectors.Systemic delivery of adeno-associated viral vectors.Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.Host determinants of adeno-associated viral vector entry.Viral infection: A key host receptor for AAV.Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation.An alternate route for adeno-associated virus entry independent of AAVR.Recent progress and considerations for AAV gene therapies targeting the central nervous system.Parvoviruses: structure and infection AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6 Modules Identification in Gene Positive Networks of Hepatocellular Carcinoma Using Pearson Agglomerative Method and Pearson Cohesion Coupling Modularity

P2860

Q26782605-715A8CD5-4216-4604-BCE4-8C40E6FFBC1B Q27681347-4FD3B173-D0AD-4406-9321-9346957DCA4C Q33586309-A7FF82F6-A000-4910-AF9E-D9EEF61AE2A2 Q34729878-57CF4ABC-4548-43CD-90EB-25B2A3952930 Q34991117-44F3728C-CA41-4B51-A347-2A62A9BA3973 Q35121258-4203A418-ADA4-422F-B68D-EB404AB21012 Q35394805-6A61D054-3C25-4B98-8BE2-3DE7585F6E19 Q35734826-F75908F0-C795-40D3-942D-6F1A7149D165 Q35857358-FC35F3AA-4868-4329-B906-BB664FBFADBB Q35876224-5A451B0F-140D-4DF5-A9C6-18070C72D978 Q35902332-E4FA0973-B960-4AA4-8E28-77FEAB1AFDE5 Q36321043-885C27DC-E534-405A-A666-EABE47C4F12A Q36367714-AC1C49C9-920B-469C-A6F0-604DECD45E1A Q36406869-5C90ADF6-6EAE-455F-9E21-7BE15BDE56DD Q36427096-BFBB14BA-CB4C-4A6D-95AD-39EE6A151429 Q36458554-0BA8FE41-3ECB-4D78-A187-912B2FDEB36F Q36867801-07B6AD45-4A90-47CA-BD7A-FA00748F3BE9 Q37043507-2308F292-ECE1-4FA4-85EE-D9E3CDF52C1D Q37385088-74DCB847-C4CF-4840-B23D-B2AD7F2BC233 Q37610916-59C7BA39-E8E1-4672-BF66-C590BF36B9FB Q37643989-D06C9CA4-28BD-4B7B-BC39-7DE2B8A971D8 Q38069585-4DB07EEF-3F46-49D1-BB86-65BE541802F2 Q38824171-4F25AC0A-EFDA-4E4D-9C72-4247413DA411 Q38908933-032D0E26-12FD-4BFE-9C4A-0CE98A354FFE Q39122342-1A52E233-C29E-46DC-A61C-722A559637D4 Q39411283-F47DA2CC-4D74-470B-BD6C-721BCA2CBE73 Q40559495-0BA07B44-7280-4DBE-A8CD-BE586B81070A Q41098235-2E6BD45A-E2EC-4D68-90B5-FB7BB6FA5D8E Q42030992-050F21D3-95B4-43E7-92E7-4295C4DEF7D3 Q42580337-80BE26FE-41A1-4B30-95F8-87C607DC2CE6 Q45873139-0D7DEFD5-0888-40FA-9C52-F7DA7FA5384E Q47300209-2BB46A11-73A4-4244-8AA9-675048235D67 Q47552291-9796A58E-D99E-4CCA-8FD7-32DF7BDB36AE Q54206545-EB174ADD-73D4-41CF-8A30-887057122473 Q56115905-4D903737-41C9-4B48-902F-C4F79674CFD7 Q58795206-B07092E8-8316-45D1-A3AE-9A28C1FCF158 Q58906461-15539F3A-93AA-41CC-9D60-B0073AA097A3

P2860

Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3

http://www.wikidata.org/entity/Q34393166

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Human hepatocyte growth factor ...... no-associated virus serotype 3

@ast

Human hepatocyte growth factor ...... no-associated virus serotype 3

@en

Human hepatocyte growth factor ...... no-associated virus serotype 3

@nl

type

label

Human hepatocyte growth factor ...... no-associated virus serotype 3

@ast

Human hepatocyte growth factor ...... no-associated virus serotype 3

@en

Human hepatocyte growth factor ...... no-associated virus serotype 3

@nl

prefLabel

Human hepatocyte growth factor ...... no-associated virus serotype 3

@ast

Human hepatocyte growth factor ...... no-associated virus serotype 3

@en

Human hepatocyte growth factor ...... no-associated virus serotype 3

@nl

P1433

Q34393166-0621AF8D-7EE6-4B83-8E96-854F0BC07A50

P1476

Q34393166-1B5D3E3F-58F7-4DCB-9723-F5B1513B466D

P2093

Q34393166-20302FE7-BFB8-4547-8499-7785807A2013

Q34393166-2A289C35-F042-4D9C-9243-8A570E642630

Q34393166-2A767613-ED41-43A0-A564-4D7633A77DB4

Q34393166-4E9769B9-28AA-4FD6-82CB-1CD5FA8B0362

Q34393166-6F6FE63B-C58A-4E83-BC69-1F477D9FBA66

Q34393166-7D8EE0D3-3440-41FF-8B3C-3371217C9222

Q34393166-B3193D45-EFD0-4EA3-9912-8AEC78B96BFC

Q34393166-BCDA9485-4FF9-48F0-ABBE-3A07BEE0B954

Q34393166-BD7546E1-6782-4B86-83B2-EAC51E7860F9

Q34393166-CB56F791-495D-45D8-A737-1537A086AF64

P2860

Q34393166-01B6B75E-DCB1-4600-9CFE-92E8236550BE

Q34393166-07FA9EEC-A21D-4624-B859-99437DAE6546

Q34393166-08BEA335-C2DE-4F09-B5AD-45A3FAD35AD0

Q34393166-0D1D160B-0755-401F-B6A3-F9C2D95EB2B2

Q34393166-1875DD42-DCED-4215-A479-A7BFCEC5F04F

Q34393166-2A182B2A-EA8F-4DB0-8FDC-3684015CD660

Q34393166-2FD98986-736F-4B31-9F6E-B6F3DE39AADE

Q34393166-354B5342-DAD3-4FD7-ADD7-32BE06DE1EFC

Q34393166-41910EBE-57AC-4786-B6CB-18F2AFEC43D2

Q34393166-48877A95-65A9-4D68-A2BA-D5E47809FCAD

P304

Q34393166-F9BB41AB-51FB-413E-989D-22BA7D107841

P31

Q34393166-8E79575B-ECA0-4D07-84CA-C9BECF71A87D

P356

Q34393166-1C372339-D6C7-41AF-967D-1BFA204311D2

P433

Q34393166-E05BB5D9-BA75-46DF-B944-E5403E48F727

P478

Q34393166-27D5DEA1-A74D-4EB3-B1BA-59CAB23FF9B8

P50

Q34393166-3A261089-F5D0-4ABA-86D3-302CDA831A1A

P577

Q34393166-22A8ED38-4218-4A3B-85E5-E5925617ED57

P5875

Q34393166-AE202B89-49BC-4A23-A91D-D794E13B3EC2

P698

Q34393166-0AF05775-0631-4541-970A-32FCDD0F9D2B

P932

Q34393166-CA714FF0-6304-4E56-A08C-385C468D56BE

P356

P1433

Human Gene Therapy

P1476

Human hepatocyte growth factor ...... no-associated virus serotype 3

@en

P2093

Arun Srivastava

http://www.w3.org/2001/XMLSchema#string

Baozheng Li

http://www.w3.org/2001/XMLSchema#string

Binbin Cheng

http://www.w3.org/2001/XMLSchema#string

Chen Ling

http://www.w3.org/2001/XMLSchema#string

Giridhara R Jayandharan

http://www.w3.org/2001/XMLSchema#string

Jasmine K Kalsi

http://www.w3.org/2001/XMLSchema#string

Katherine E McGoogan

http://www.w3.org/2001/XMLSchema#string

Lakshmanan Govindasamy

http://www.w3.org/2001/XMLSchema#string

Li Zhong

http://www.w3.org/2001/XMLSchema#string

Samantha W Y Gee

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

Growth of human hepatoma cells lines with differentiated functions in chemically defined medium

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

Cloning and characterization of adeno-associated virus type 5.

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

P304

1741-1747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2010.075

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Mavis Agbandje-McKenna

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44670805

http://www.w3.org/2001/XMLSchema#string

P698

20545554

http://www.w3.org/2001/XMLSchema#string

P932

2999576

http://www.w3.org/2001/XMLSchema#string